A groundbreaking technology designed to attack lung tumors and shorten recovery times for patients is now available at St.

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...

Alan faced the prospect of losing his bladder when he was diagnosed with bladder cancer in 2020. Now he’s in remission thanks ...

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

Researchers are developing an in vivo approach to engineer cancer-fighting immune cells, potentially making the powerful CAR ...

The Trump administration's broadside against higher education's ideological rot should not stop at Harvard, it should only ...

The daughter of a Bridgeport Navy veteran who died of cancer is hosting a swim-a-thon fundraiser in his honor. The proceeds ...

T therapies is an expensive business. The fundamental problem is that CAR-T production is not a good fit for centralized manufacturing.

MIAMI, FL / ACCESS Newswire / May 29, 2025 / Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the ...

For the third year in a row, a group of runners will lace up their shoes and take to the streets of Dublin this weekend for ...

Discover how Unicorn Biotechnologies is revolutionizing lab workflows with cell culture automation. Expert insights from ...

Police dug into Erin Patterson’s bank records, shopping history and phone records as part of their probe into a lunch that ...